UK Healthcare Gazette
SEE OTHER BRANDS

Your healthcare and wellness news from the United Kingdom

UK Healthcare Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Healthcare Gazette.

Press releases published on August 12, 2025

Encompass Life’s Groundbreaking Coaching Method Brings Lasting Relief to Body and Soul
Contraceptive Device Market Expected to Hit USD 42.5 Billion by 2035 with a Remarkable 3.05% CAGR
Non-Surgical Aesthetic Device Market is Projected to Reach USD 6.5 Billion, with a Robust 5.4% CAGR Till 2035
Neurovascular Thrombectomy Device Market is Poised to Growth USD 4.5 Billion by 2035 with Thriving CAGR of 5.54%
Nitinol Medical Device Market Anticipated to Reach USD 6.5 Billion, at a Notable 5.4% CAGR by 2035
Citizen Octopus Launches Research Effort Using Social Media Data to Identify Hidden Health Patterns
'They’re Trying to Kill Us' Now Streaming on UnchainedTV
Your Space Might Be Hacking Your Brain Right Now — Space Performance Specialist Provides New Insights On Why And How
LuggageToShip.com Launches AI-Powered Global Shipping Marketplace
Abalone Bio and Mount Sinai Publish Preclinical Data on World's First CB2 Antibody Agonists
Revolutionary GLP-1 Tracking App Solves Ozempic & Wegovy Users' Biggest Problem After 3,000-Person Beta Test
Polaris Quantum Biotech Unveils QuADD: Next-Generation Quantum-AI Drug Discovery Platform - Beta Testers Wanted
PayToMe.co Named Semi-Finalist in Pepperdine’s Most Fundable Companies® 2025
ancora Announces Most Significant Platform Update to Date with Major Functional Enhancements Across All Components
Karmascore, a Relationship Management App Launches Workplace Wellness Platform to Combat Toxic Culture and Turnover
Clairvoyant Networks, Inc. Ranks No. 2280  on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
Injectable Ketamine Market to Surpass $3.42 Billion by 2034, Fueled by Rising Demand for Mental Health & Pain Therapies
Duchenne Muscular Dystrophy Drugs Market Size Outlook: $14.04 Billion Valuation by 2034 with a Robust 16.8% CAGR
Healthcare Innovator’s New Book Establishes Communication Framework for Patient-Directed Care
Genetically Engineered Mouse Model Provides Insights on Genetic Bone Disorders

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions